Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified March 2013 by University of Michigan Cancer Center
Sponsor:
Collaborators:
GlaxoSmithKline
Gilead Sciences
Information provided by (Responsible Party):
Scott Gitlin, MD, University of Michigan Cancer Center
ClinicalTrials.gov Identifier:
NCT01528865
First received: January 12, 2012
Last updated: March 20, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: August 2016
  Estimated Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)